InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Farid Marjan. Insider active across 2 companies, notably Kala Pharmaceuticals, Inc.. Aggregated, 4 disclosures have been logged. History available since 22 June 2023. The latest transaction was filed on 15 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Farid Marjan has 4 filings in total, all within the recent sampled filings between 2023-06-02 and 2025-06-17. He is a Director at KALA BIO, Inc. and Kala Pharmaceuticals, Inc., and the modal transaction nature is Attribution; the buy and sell amounts are both EUR 0 in this sample.